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Available online 7 April 2016Lyme Borreliosis is a common tick-borne disease of the northern hemisphere caused by the spirochaetes of the
Borrelia burgdorferi sensu lato (B. burgdorferi s. l.) complex. It results inmulti-organ diseasewith arthritic, cardiac,
neurological and dermatologicalmanifestations. In the last twenty-ﬁve years there have been over 500 reports of
anAustralian Lyme-like syndrome in the scientiﬁc literature. However, the diagnoses of LymeBorreliosismade in
these cases have been primarily by clinical presentation and laboratory results of tentative reliability and the true
cause of these illnesses remains unknown. A number of animals have been introduced to Australia thatmay act as
B. burgdorferi s. l. reservoirs in Lyme-endemic countries, and there are some Australian Ixodes spp. and
Haemaphysalis spp. ticks whose geographical distribution matches that of the Australian Lyme-like cases. Four
published studies have searched for Borrelia in Australian ticks, with contradicting results. The cause of the
potential Lyme-like disease in Australia remains to be deﬁned. The evidence to date as towhether these illnesses
are caused by a Borrelia species, another tick borne pathogen or are due to a novel or unrelated aetiology is
summarised in this review.
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Lyme Borreliosis is a common tick-borne disease of the northern
hemisphere. It is caused by spirochaetes of the Borrelia burgdorferi
sensu lato (B. burgdorferi s. l.) complex. Typically, the disease ﬁrst pre-
sents with an erythemamigrans rash at the site of the tick bite, followed
by ﬂu-like symptoms and later by debilitating arthritic, dermatological
and neurological manifestations. The bacteria are transmitted by Ixodes
species ticks, although other Ixodidae ticks [1–4] and haematophagous
arthropods [2,4–14] have been implicated in carrying the bacteria. Bac-
terial reservoirs of the disease are usually small mammals, birds and oc-
casionally reptiles [15,16]. The presence or absence of Lyme disease (or
a Lyme-like disease) in Australia remains a contentious issuewith vary-
ing opinions being held bymedical practitioners, scientists and lay stake
holders while the aetiological agent remains undetermined.
In response to the continued controversy and media attention
regarding the possibility of there being Lyme Borreliosis in Australia,
the Australian Government Chief Medical Ofﬁcer, Professor Chris
Baggoley, established the Clinical Advisory Committee on Lyme Disease
(CACLD) in 2013 [17]. The purpose of this committee was to advise the
Chief Medical Ofﬁcer on the following points:
1. The extent to which there is evidence of Borrelia species causing ill-
ness in humans in Australia
2. The most appropriate laboratory diagnostic testing algorithms (best
world practice) for persons who have suspected Borreliosis in
Australia
3. The most appropriate treatments for Borreliosis in Australia
4. The most appropriate ways to disseminate information to health
professionals and the general public on Borreliosis/Lyme disease
5. The requirements for further research into Borreliosis in Australia,
and the generation of appropriate new questions relevant to the
terms of reference.
Furthermore, the Australian Government Department of Health
commissioned a scoping study [18] to identify the gaps in scientiﬁc
evidence surrounding the causative agent of the Australian Lyme-like
disease. Subsequently, upon advice from the CACLD, the Australian
public was called upon to review and contribute to the scoping study,
and 36 submissions were obtained in total. All points raised were con-
sidered individually and then collated, culminating in the following
twelve considerations [18]:
1. Does B. burgdorferi s. l. occur in Australian ticks, and especially in
Ixodes holocyclus?
2. Do other Australian tick species transmit Lyme Borreliosis?
3. Can Australian ticks be infected with, maintain, and transmit
B. burgdorderi s. l.?
4. Can we ﬁnd better diagnostic tools to search for Lyme Borreliosis?
5. Is there an indigenous species of Borrelia in Australia able to infect
humans and able to cause a Lyme disease-like syndrome?
6. Do other possible pathogens occurring in Australian ticks cause a
Lyme disease-like syndrome?
7. Are there any relapsing fever group Borrelia species in Australia?
8. Can B. burgdorferi s. l. be detected with any certainty in erythema
migrans rashes following a tick bite, as demonstrated by PCR and/
or culture of biopsy specimens?
9. Is there an immune response to B. burgdorferi s. l. or to any other
possible agent in the sera of patients presenting with a Lyme
disease-like syndrome?10. Are there any B. burgdorferi-speciﬁc IgG antibodies in the sera of
patients with Lyme disease-like syndrome?
11. If there is evidence found to indicate the presence of Lyme
Borreliosis or a Lyme disease-like syndrome in Australia, what is
the geographic spread of cases?
12. Are there other potential vectors that could transmit Borrelia in
Australia?
Further to the above identiﬁed knowledge gaps, during the course of
this literature review, the authors will consider two further points of
investigation:
1. Could native Australian animals act as reservoirs of B. burgdorferi s. l.?
2. Could introduced animals such as foxes, hares, placental mice and
rats act as reservoirs of B. burgdorferi s. l. in Australia?
The purpose of this review is to assess the current situation of the
controversial Lyme or Lyme-like illness reported by some to be present
in Australia. The existing evidence is explored and areas require further
investigation are identiﬁed. Alternative infectious and non-infectious
diagnoses are also considered.
2. Potential reservoirs of Lyme Borreliosis-causing Borrelia species
in Australia
If a Borrelia causing a Lyme-like disease is present in Australia, im-
portation or native evolution are both possible origins of the causative
agent. Such an agent might be a known Borrelia species or a novel, as
yet undescribed microbial pathogen.
2.1. Borrelia in introduced animals
In the 1900s, two species of Borreliawere introduced to Australia via
the agricultural industry. These were Borrelia theileri, the worldwide
cause of bovine Borreliosis [19], and Borrelia anserina, the worldwide
agent of avian spirochaetosis [20]. B. theileri has been reported in cattle
of Queensland and New SouthWales [21–23] and B. anserina has infect-
ed poultry of Victoria and the Northern Territory [23–25]. B. theileri is
transmitted in Australia by the cattle tick Rhipicephalus (Boophilus)
australis [21,26] while the vector of B. anserina is Argas persicus s. l.
[27]. Argas persicus ticks have been observed in all states of Australia
except for Tasmania, and R. australis is distributed along the northern
and eastern coasts of Australia [26]. R. australis may occasionally
bite humans [26]. Neither B. anserina nor B. theileri belong to the
B. burgdorferi s. l. complex, nor have they ever been described as causing
a Lyme-like illness in humans.
If LymeBorreliosis was present in Australia, it is reasonable to expect
that its presence would be prominent in livestock, domestic animals
and particularly feral deer, as is the case with Lyme Borreliosis in the
northern hemisphere. However, very few cases of a Lyme-like illness
in Australian animals are present in the veterinary literature. Lyme
Borreliosis was reported in two cows at Camden, New South Wales in
1989 [28]. These cows were previously infested with Haemaphysalis
longicornis (see Section 2.5) and presented with fever, anaemia, poor
condition and polyarthritis. The diagnosis of Lyme Borreliosis was
made in the ﬁrst cow on the presence of spirochaetes in the synovial
stroma and the second by positive IFA Lyme serology. However, from
the images of spirochaetes from the ﬁrst case described in the paper it
is unclear if these represent true spirochaetes or artefact. Ephemeral
fever, chlamydiosis,Mycoplasma bovis and “other septicaemic bacteria”
were ruled out in the cows, but it is unspeciﬁed if B. theileriwas one of
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react with B. burgdorferi s. l. [29]. This agent can cause fever and anae-
mia, although is not associated with polyarthritis [30–33]. Conversely,
polyarthritis has been associated with B. burgdorferi s. l. in animals in
the northern hemisphere [30]. However, true Lyme Borreliosis was
not conﬁrmed by the diagnostic techniques performed in these cases,
and it is possible that these cases were B. theileri infection. Overall, the
relative absence of reports of veterinary cases of Lyme or a Lyme-like
disease in Australia suggests the absence of traditional Lyme Borreliosis
causing agents in the country.
2.2. Borrelia in native animals
Reports of “Borrelia species” in Australian native animals appear to
be localised to Queensland. In Brisbane, spirochaetes observed in
blood ﬁlms of bandicoots, and in western Queensland spirochaetes
were seen in blood ﬁlms of kangaroos were both identiﬁed as a novel
Borrelia species [34]. The identiﬁcation of these Borrelia to the species
level was not determined, and their place in the phylogeny of the
Borrelia genus remains unknown. Molecular characterisation methods
were not available at the time and morphological appearance alone
was used to classify these into the Borrelia genus. Due to their presence
in blood ﬁlms, it is hypothesized that these spirochaetes were likely to
be relapsing fever Borrelia rather than Lyme-causing Borrelia, since the
latter generally have amuch lower spirochaetal load in the bloodstream
than the former. Once again, modern phylogenetic analysis techniques
that would have deﬁnitively placed these spirochaetes into Lyme-
causing or relapsing fever Borrelia, or another genera of spirochaete
altogether were not available to conﬁrm these diagnoses. In 1956,
Pope and Carley isolated a spirochaetes from one native rat (Rattus
villosissmus) out of twenty-seven dead and dying rats tested in
Richmond, north-western Queensland [35] and named it Borrelia
queenslandica [36]. Attempts to infect a human volunteer with this
spirochaetes were unsuccessful [37] and attempts to transmit the
spirochaete from mouse to mouse via the Argasid tick Ornithodorus
gurneyi were also unsuccessful [38]. Due to loss of all isolates, whether
B. queenslandica is a part of the B. burgdorferi s. l., a relapsing fever
group or another genus of spirochaete cannot now be determined.
However, the lack of pathogenicity in the human volunteer are
counterindicative of this organism being the causative agent of the
Australian Lyme-like disease considered in this paper.
2.3. Spread of Borrelia by migratory birds
Birds play an important role in the perpetuation of ticks and
B. burgdorferi s. l. in North America [39,40], Europe and Asia [41–43].
More signiﬁcantly there is evidence that bird migration results in a
wider dispersion of Lyme-causing Borrelia. Examples of this include
the detection of B. burgdorferi s. l. in migratory songbirds across
Canada [40] and the transport of Borrelia garinii via birds migrating
frommainland Asia to Japan [42]. Most relevant to the Australian situa-
tion is the worldwide dispersal of seabird species and the seabird tick
Ixodes uriae [44–46]. B. garinii, a species known to cause Lyme
Borreliosis, has been detected in I. uriae not just in the northern hemi-
sphere [46,47], but also in southern hemisphere locations including
Campbell Island off New Zealand, the Crozet Islands in the southern
Indian Ocean and the Falkland Islands off South America [46]. This
transhemispheric dispersal of B. gariniimaybe not just due to the spread
of infected ticks, but also by seabirds acting as B. garinii reservoirs.
However, the theoretical spread of B. garinii from seabirds to humans
and even other birds andmammals, is unlikely, as generally the seabirds
and their ticks are restricted to the open sea, remote islands, and penin-
sulaswhere contact with other animals is rare [46]. The ticks of seabirds
along the Australian coast have not to date been investigated for
Borrelia.2.4. Introduced animals identiﬁed as Lyme reservoirs overseas
A number of non-native mammals have been introduced to
mainland Australia since its settlement [48], some of which are known
reservoirs of B. burgdorferi s. l. in the northern hemisphere.
Several introduced animals found in Australia, including the black
rat (Rattus rattus), the house mouse (Mus musculus), the brown hare
(Lepus europaeus), several species of deer and to lesser extents the red
fox (Vulpes vulpes) and the Norwegian rat (Rattus norvegicus) are
known to be reservoirs of B. burgdorferi s. l. in the northern hemisphere.
Most of these animals have established widespread populations in
Australia since their introduction, excepting the Norwegian rat, which
has established a localised population only [48]. In Australia, R. rattus
and R. norvegicus in Australia are parasitised by I. holocyclus and Ixodes
tasmani ticks [26,49], M. musculus is parasitized by I. tasmani, and
L. europaeus is parasitized by H. longicornis [26]. No studies on the
ticks commonly parasitising L. europaeus in Australia have been
performed, but these hares tend to occur in open grassland, which is
not a preferred habitat of Ixodes ticks. To date, no investigations have
been conducted into the presence or absence of B. burgdorferi s. l. in
introduced undomesticated animals of Australia.
2.5. Likely tick vectors of B. burgdorferi s. l. in Australia
Overall very little evidence exists of the transmission of a potential
Lyme-like disease by Australian ticks. It is hypothesised that if ticks
are transmitting B. burgdorferi s. l. in Australia, the tick species would
parasitize a number of hosts including humans, and would likely (but
not necessarily) be of the Ixodes genus, as this is the genus that transmits
LymeBorreliosis in thenorthern hemisphere. The following information
is intended only to identify the need for further research in testing for
the presence of B. burgdorferi s. l. in wild populations of these ticks,
and if B. burgdorferi s. l. is present, their transmission competency.
In the northern hemisphere, the Lyme-causing Borreliae are trans-
mitted mainly by Ixodes species ticks. Nineteen species of Ixodes have
been described in Australia [49], many of which have only a small
geographical distribution (e.g. Ixodes vestitus and Ixodes myrmecobii
are localised to Western Australia) or a limited host range (e.g. Ixodes
vespertillionis is conﬁned to bats and Ixodes ornithorhynchi to the
platypus) [49]. It should be noted that the main ticks that transmit
Lyme Borreliosis in the northern hemisphere are the black-legged
ticks (the ricinus complex [50]) and that there are none of this group
found in Australia. I. holocyclus and I. tasmani appear to have the widest
geographical spread of the Australian Ixodes species while also having a
large range of potential hosts. Furthermore, I. myrmecobii occurs in WA
and belongs to the same subgenus (Sternalixodes) as I. holocyclus [51].
I. tasmani is themost abundant species of tick in Tasmania but is also
found throughout Victoria, along the coastal and sub coastal areas in
New South Wales and Queensland and in parts of southeast South
Australia and southwest Western Australia [26]. I. tasmani has a broad
range of hosts, but rarely bite humans, making it a candidate as a tick-
borne disease reservoir and bridge vector of any putative tick borne
Lyme-like agent in Australia, but an unlikely candidate vector to
humans. Examples of hosts it parasitises include possums, bandicoots,
wallabies, native rats, introduced rats, dogs, cats, horses and humans.
Nowork has been published regarding the potential vector competence
of I. tasmani for B. burgdorferi s. l.
I. holocyclus, colloquially known as the “paralysis tick”, has an exten-
sive host range including, but not limited to, domestic animals such as
cats, dogs, chickens and other fowl, ducks and man [26]. Native animal
hosts include wallabies, kangaroos, bandicoots, possums and dingoes
[26]. I. holocyclus is distributed along coastal areas of northern and east-
ern coasts of Queensland and New SouthWales, Victoria and Tasmania.
In southern Queensland and northern New South Wales its range also
extends somewhat further inland [49]. This geographic distribution co-
incideswith that of the Lyme-like disease cases reported in the scientiﬁc
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illness being present in Western Australia, outside of the range of
I. holocyclus, no cases have been published in the scientiﬁc literature.
However, in a vector competence experiment, I. holocycluswas able to
ingest but not transmit the JD1 strain of B. burgdorferi s. s. [52]. Whilst
this ﬁnding does not preclude the capacity of I. holocyclus to transmit
other B. burgdorferi s. l. species or strains, it does infer a likelihood of
poor vector competence for this species.
In the northern hemisphere, B. burgdorferi s. l. has also been detected
in Ixodidae (hard tick) of genera other than Ixodes [1–4] and even in
haematophagous arthropods including lice [2], ﬂeas [4,5], keds [2,6],
mites [7–9], ﬂies [10–12] andmosquitoes [9,13,14].While the transmis-
sion capability of these arthropods remains undetermined, it does raise
the possibility of Lyme transmission by arthropods other than Ixodes. In
Australia, other genera of hard ticks include Amblyomma,Haemophysalis,
Bothriocroton and Rhipicephalus. These vary in their distribution and host
range depending on the species. The “bush tick” H. longicornis is a native
of the south-east coast of Russia, North and South Korea, Japan and China
[26] and is believed to have been introduced to Australia in the nine-
teenth century from Japan [63]. In Australia, H. longicornis occupies a
large coastline area spanning from central Queensland to south-eastern
Victoria but is found especially in Kempsey, New South Wales [26]. A
very small area in the south-western corner of Western Australia
also contains H. longicornis [64]. Similar to I. holocyclus, H. longicornis
parasitises a large number of hosts in Australia including but not limited
to cattle, sheep, horses, dogs, cats, hares, domestic fowls, Australian
magpies and marsupials [26], but only rarely bites humans [26]. The
detection of B. burgdorferi s. l. in H. longicornis ticks of Japan [65] and
China [3] supports the possibility that H. longicornis could carry Lyme
Borreliosis in Australia.
2.6. Studies investigating Borrelia in Australian ticks
Four studies have been published that investigated the potential for
B. burgdorferi s. l. in ticks, both employing culture with or without PCR
and in the most recent studies, next generation sequencing.
2.6.1. Wills and Barry 1991
Wills and Barry [66] published preliminary results of their investiga-
tions into the presence of Borrelia in Australian ticks in a letter to the
editor of The Medical Journal of Australia in 1991. One-hundred andFig. 1. Locations of Australian Lyme-like cases published in the scientiﬁc literature.
Speciﬁc location based on town, suburb or GPS coordinates. Approximate location
based on broad location description, e.g. “rural Victoria” or “Hunter Valley”.sixty-seven ticks consisting of I. holocyclus and H. longicorniswere col-
lected from the Hunter Valley and Manning River districts of coastal
New South Wales and their midguts were cultured in BSK-II media.
Within 8 weeks incubation, motile, rigid spirochaete-like objects
(SLOs) were observed in 44% of their I. holocyclus cultures and 35% of
theirH. longicornis cultures; a total of 70 Australian tickmidgut positive
cultures out of 167 cultured. The individual number of I. holocyclus
midguts and H. longicornis midguts cultured was not speciﬁed. The
presumptive spirochaetes were described as “large, coiledmotile bacte-
ria with an irregular rotational movement” and were “morphologically
indistinguishable” to the reference strain B. burgdorferi (B31). At least
four of the spirochaetes isolated shared antigenic epitopes with
B. burgdorferi as demonstrated by ELISA, immunoﬂuorescence and
western blotting, suggestive of Borrelia species. However, details of the
laboratory methods are not published and the organisms recovered
were not made available for conﬁrmation by another laboratory,
rendering the experiment unable to be replicated. False positives in
the ELISA, immunoﬂuorescence and western blotting cannot be ruled
out. No PCR or sequencing has been conducted to conﬁrm the identity
of the isolates, and positive Borrelia cultures from Australian tick sam-
ples have not been reproduced to date. Although this investigation
was conducted as a part of the author's (Wills') PhD, no follow-up report
to these preliminary ﬁndings was ever published in the scientiﬁc
literature.
Alleged L-form variant “rigid” SLOs of Borrelia have been described
in other papers, from cultured biopsy and synovial ﬂuid samples from
Lyme Borreliosis patients [67,68], in animal skin sample cultures [69]
and in control Borrelia cultures subjected to antispirochaetal agents
[70,71]. However, the SLOs in contaminated cultures observed under
electron microscopy have been identiﬁed by some researchers [69,72,
73] as large ﬂagella aggregates from the contaminating bacteria, and
therefore not indicative of the presence of Borrelia spirochaetes.
Furthermore, cultures of Bacillus have been identiﬁed as capable of pro-
ducing these structures [74]. It is possible that this is whatwas observed
in the cultures conducted by Wills and Barry [66]. However, this does
not explain the return of such rigid SLOs to normal, motile spirochaetes
after multiple subcultures [66,67]. SLOs in uncontaminated cultures
have been observed by others and can be explained by the ﬂagella
passing though ﬁlters that block whole bacteria and the ﬂagella then
coalesce to form the long SLOs (Doggett, S. pers. comm. 2016). The
use of molecular techniques, especially sequencing, would be ideal for
conﬁrmation or dismissal of any cultured SLOs as Borrelia.
2.6.2. Russell et al. 1994
A comprehensive search for Borrelia in Australia conducted by
Russell et al. [73] contradicted the ﬁndings of Wills and Barry [66].
Approximately 12,000 ticks were collected over three years along the
New South Wales coast. Ticks were collected from natural habitats
and removed from native and domestic animals, although the animal
species are not disclosed. The majority of tick species collected were
I. holocyclus (7922) followed byH. longicornis (2208) andHaemaphysalis
bancrofti (1092). The remaining 786 ticks consisted of nine other
species. Tick midguts were cultured in BSK-II media and screened by
dark-ﬁeld microscopy, although factors including nutritional media
components, chemical and physical culture conditions were adjusted
in an unspeciﬁed number of cultures. Ninety-two cultures of bloodfed
ticks revealed SLOs. These SLOswere straight, rigid and uniformly coiled
and non-motile and later determined to be bacterial ﬂagella aggregates
by electron microscopy. The authors describe “a few” of the 18 SLOs as
having tested positive using polyclonal B. burgdorferi s. s. antibodies,
though none reacted with monoclonal B. burgdorferi s. s. antibodies.
The study found “no deﬁnitive evidence for the existence in Australia
of B. burgdorferi the causative agent of true Lyme Borreliosis, or for any
other tick-borne spirochaete that may be responsible for a local
syndrome being reported as Lyme disease”. The authors observed
Wills' and Barry's [66] cultured Borrelia and found them to be identical
Fig. 2. Assessing the cause of a patient's Lyme-like disease. a Perform only in NATA-accredited laboratory. b Paired serum testing must be performed. Only consider positive if there is a 4-
fold rise in titre, or seroconversion is observed. Positive results without 4-fold rise or seroconversion only indicate past exposure and not current infection. A third serum sample may be
required if equivocal. EM, erythema migrans; ELISA, enzyme-linked immunosorbent assay; IFA, immunoﬂuorescence assay; and EBV, Epstein-Barr virus.
46 M.J. Chalada et al. / One Health 2 (2016) 42–54to their own SLOs, concluding that Wills' and Barry's cultured SLOs
were also contaminant ﬂagella aggregates. Russell et al. also had the
advantages of Borrelia genus-speciﬁc PCR and a much larger sample
size over Wills' and Barry's study. The conclusion of Russell et al.'s
study – that no spirochaetes were able to be identiﬁed through culture
or molecular methods in Australian ticks – therefore seems more
plausible than the conclusions of Wills and Barry.2.6.3. Gofton et al. 2015a
A recent study by Gofton et al. found no B. burgdorferi s. l. in
Australian I. holocyclus ticks, but did detect a novel relapsing fever
group Borrelia [75]. This study tested 109 I. holocyclus from around
New South Wales, collected over a ten year period. DNA extracted
from these ticks was subjected to next generation sequencing to deter-
mine the bacteriome of the ticks. Thirty Ixodes ricinus ticks collected in
Germany were included for comparative purposes. Whilst
B. burgdorferi s. l. sequences were not recovered from any Australian
I. holocyclus ticks, nine (30%) of the German I. ricinus samples yielded
16SrRNA sequences homologous to either B. burgdorferi s. s. or Borrelia
afzelii [75]. A single Australian I. holocyclus taken from an echidna
yielded 16SrRNA sequences of an unknown Borrelia species, clustering
within the relapsing fever group and not the B. burgdorferi s. l. group
of Borreliae [75].This work provides further evidence that the cause of the Lyme-like
illness in Australia may not be a member of the B. burgdorferi s. l. com-
plex. The ﬁnding of a novel relapsing fever Borrelia in an Australian
monotreme does provide evidence for the presence of Borreliae in
Australia, but it is not known if this organism can infect humans, and
should it do so, it is likely that it would present as a relapsing fever ill-
ness rather than with Lyme-like symptoms. These factors limit the like-
lihood that this novel Borrelia species is the cause of the Lyme-like
illnesses seen in Australia. The study was limited by the relatively low
number of ticks sampled and the limited geographic range from
which they were collected. No data was presented regarding the
distribution of collection sites (urban, rural or wilderness) within that
state.
2.6.4. Gofton et al. 2015b
In the above study, only one species of tick, I. holocyclus, was
õsampled in this study [76]. Although it is assumed that this is the
most likely vector candidate in Australia by many researchers, as
noted in Section 2.5 of this review, this species has been shown not to
be able to transmit B. burgdorferi s. s. in vector competence studies.
H. longicornis, with its wider geographic range and known competence
as a vector of Lyme-causing Borrelia in Japan, would be a superior candi-
date for potential B. burgdorferi s. l. transmission in Australia, except that
it very rarely bites humans. Further work using the same protocol on a
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other tick species (particularly H. longicornis) is warranted. Gofton
et al. addressed this requirement in a recently published study of 460
ticks collected from below the line of the tropic of Capricorn inWestern
Australia and the seaboard Eastern Australia (though one from inland
Queensland was included). The ticks were identiﬁed as being 279
I. holocylcus, 167 Amblyomma triguttatum, seven H. bancrofti and a
further seven H. longicornis. Midguts of all ticks were subjected to 16s
ribosomal RNA PCR and next generation sequencing. A Borrelia genus
speciﬁc ﬂaB nested PCR was also performed on all ticks recovered.
None of the ticks concerned yielded any Borrelia sequences or PCR
products [76].
3. Relevance of diagnostic techniques to Australia
3.1. Diagnosis in the endemic setting
In the Lyme Borreliosis endemic United States of America (USA), se-
rology for Lyme Borreliosis is the diagnostic technique recommended
by the Centers for Disease Control and Prevention (CDC) [54]. Serology
is conducted by a two tiered approach: ﬁrstly, an enzyme-linked immu-
nosorbent assay (ELISA) or immunoﬂuorescence antibody (IFA) test is
performed, and if positive, this is followed secondly by an immunoblot.
The ELISA or IFA tests may give false-positive reactions in the presence
of other infectious, autoimmune or inﬂammatory conditions [53,54].
Similarly, not performing the ELISA or IFA step will increase the likeli-
hood of false positives in the immunoblot [57].
The interpretation of the immunoblot depends on the number
of bands present. In the USA, where B. burgdorferi sensu stricto
(B. burgdorferi s. s.) is the only causative agent of Lyme Borreliosis, the
following criteria are required for diagnosis: An IgM immunoblot is
positive if two of the three bands are present: 24 kDa (OspC), 39 kDa
(BmpA), and 41 kDa (Fla) [56]. An IgG immunoblot is considered
positive if ﬁve of the following 10 bands are present: 18 kDa, 21 kDa
(OspC), 28 kDa, 30 kDa, 39 kDa (BmpA), 41 kDa (Fla), 45 kDa, 58 kDa
(not GroEL), 66 kDa, and 93 kDa [55]. In patients with acute Lyme
Borreliosis (less than 30 days) within the USA, the IgM blot has a sensi-
tivity of 58.5% and speciﬁcity of 92% to 94% [56]. In patients greater than
30 days after initial infection, the IgG blot has a sensitivity of 83% and
speciﬁcity of 95% [55].
In Europe and Asia there are a greater number of B. burgdorferi s. l.
species and strains that cause Lyme Borreliosis than there are in the
United States [60,61]. Different strains of B. burgdorferi s. l. may express
only someof the antigens detected in immunoblot,may constitutionally
lack certain genes for certain proteins, or comprise immunodominant
antigens of molecular weights that differ from those typically used in
the immunoblot. For these reasons, the immunoblot interpretation
using amethod developed at one geographic areamay not be applicable
to other geographic areas. Consequently, standardisation of immuno-
blotting methods for Lyme Borreliosis diagnosis in Europe and Asia is
unfeasible [60,61]. A number of commercial immunoblot kits and inter-
pretative criteria are available with varying speciﬁcity and sensitivity
[62].
3.2. Confounding factors in serological diagnosis in the non-endemic setting
TheCDCdiagnostic serologicalmethodused forB. burgdorferi s. s. is in-
appropriate for use in the Australian context except for patients with a
travel history to endemic countries [59]. It is possible that any theoretical
Australian B. burgdorferi s. l. species would cause a different serological
response in a Lyme Borreliosis patient than the American, Asian or
European species. Such antigenic differences could result in false negative
serology results. It has been shown that chronic Lyme Borreliosis patients
may test seronegative even if they are PCR conﬁrmed or culture
conﬁrmed to be infected by B. burgdorferi s. l. [58,77]. This does not neces-
sarily mean that these patients lack an antibody response, but rather thebanding pattern in an immunoblot is merely different to that of the stan-
dard diagnostic criteria [78]. This must be considered in regard to almost
all of thepurported Lyme-like illness cases seen inAustralia,which almost
exclusively [79–82] presentwith clinical symptoms correlating to the late
(greater than 30 days duration) stage of Lyme Borreliosis.
It is important to consider that in areas not endemic for Lyme
Borreliosis, the positive predictive value of the serology test will be
low [59]. In endemic areas, patients with other illness and even healthy
donors may display at least 5 of the 10 bands required for a positive
anti-B. burgdorferi IgG western blot result [56]. Furthermore, in the
non-endemic setting of Papua New Guinea, 50% of 84 individuals
screened for Lyme Borreliosis ﬁtted the CDC serological criteria for
Lyme Borreliosis [83]. Further testing of these samples for antibodies
to Treponema pallidum by microhaemagglutination assay, rapid plasma
reagin test, ﬂuorescent treponemal antibody-absorption test, and
Western blot all yielded negative results. The pattern of IgG bands
seen differed from controls with conﬁrmed Lyme Borreliosis and none
of the patient sera inhibited the growth of B. burgdorferi in vitro, whilst
69% of Lyme patient sera will do so [83]. It was thought that the false
positive Lyme serology results were the consequence of high levels of
immunoglobulin or cross-reactive antibodies residents of tropical
regions [83]. It is possible this same phenomenon may occur in
Australia. While the causative agent of the putative Lyme-like disease
remains unknown, any positive or negative Lyme serology results are
unreliable.
3.3. The RCPA protocol for the diagnosis of Lyme Borreliosis in Australian
patients
The many confounding factors inﬂuencing Lyme Borreliosis diagno-
sis in Australia led to the release in 2014 by the Royal College of Pathol-
ogists of Australasia (RCPA) of a position statement on the diagnostic
laboratory testing for Lyme Borreliosis [59]. This position statement
sought to address misinformation regarding the Lyme Borreliosis in
Australia and to provide guidance to clinicians in regard to ordering
tests for the diagnosis of potential Lyme Borreliosis cases. This very
balanced statement noted that Australia was amongst several countries
inwhich the presence of local Lyme Borreliosis had not been conﬁrmed.
It outlined the expected clinical symptoms of a patient with Lyme
Borreliosis, summarised the diagnostic difﬁculties in inherent in labora-
tory diagnosis, particularly the potential for false positive results in low
or zero prevalence such as Australia. The position statement also made
several recommendations for laboratory investigation of suspected
Lyme Borreliosis cases in Australian patients [59]. The Lyme Disease
Association of Australia put out its own position statement which was
critical of the RCPA's, however it is interesting to note that they too
are now labelling this disease as Lyme-like [156].
It was recommended in the RCPA's position statement that serolog-
ical diagnosis of Lyme Borreliosis in Australia should consist of an EIA
followed by a conﬁrmatory western blot. It is noted that Australian ref-
erence laboratories can effectively diagnose Lyme Borreliosis in affected
patients who have returned from a known Lyme endemic area who
contracted the infection over four weeks previously. Laboratory tests
with unconﬁrmed efﬁcacy of diagnosis, such as measurement of CD57
lymphocyte counts and PCR on urine for the detection of B. burgdorferi
s. l. DNA, were not indicated as relevant to the diagnosis of Lyme
Borreliosis. Importantly, the report recommended that testing should
only be performed in NATA/RCPA accredited laboratories, and patients
and their doctors were advised to exercise caution in the interpretation
of result fromnon-accredited laboratories in Australia and overseas that
have not been validated to diagnose Lyme Borreliosis based upon inter-
national consensus documents. The position statement did allow for the
culture and PCR of erythema migrans-type rash biopsies collected by
interested doctors from patients with no travel history outside
Australia for research purposes [59]. The authors of this review encour-
age such testing (see Fig. 2), as it will allow the collection of data,
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of the cause of the Lyme-like illness reported inAustralia. If no infectious
agents were recovered, over time and with sufﬁcient specimen num-
bers, a large body of negative evidence by molecular and phenotypic
methods from such testing would almost deﬁnitively exclude
B. burgdorferi s. l. as the cause of this illness in Australia.
4. Lyme-like case reported in Australia
A literature search for Australian Lyme-like cases was performed
using the Google scholar search bar at https://scholar.google.com.au/
and the PubMed Advanced Search Builder at http://www.ncbi.nlm.nih.
gov/pubmed/advanced. A boolean search involving “Lyme”, “Disease”
and “Australia” was used. The search was limited to Academic Journals
only and no time framewas set for the search. A further boolean search
using the same limiters was then performed using the terms “Borrelia”
and “Australia”. Finally, any further Australian-relevant articles refer-
enced within these articles that did not come up in the initial search
were obtained. Papers that had Australian authors but were otherwise
irrelevant to Australia were removed. At least 525 human cases
[79–82,84–89] and two bovine cases [28] of Lyme-like illness have
been mentioned in the scientiﬁc literature. Only the Lyme-like cases
with speciﬁed locations are portrayed in Fig. 1, and only those with de-
tailed case presentation, diagnosis and location are presented in Table 1.
It should be noted that themajority of these are Lyme-like cases that are
suspected, but not conﬁrmed to represent cases of Lyme Borreliosis.
Unreliability of the published case reports in their diagnostic methods
means the evidence for Australian Lyme-like cases remains quite
unsubstantial and unconvincing.
4.1. Serology from patients
Several patients have been diagnosed as having likely Lyme
Borreliosis in Australia solely upon the basis of positive results by one
of several methods. The limitations of Lyme serology in Australian pa-
tients are discussed in Section 3.2. Over 200 Australian patients (and
one Australian cow) presenting with a Lyme-like disease have tested
“positive” for Lyme Borreliosis serology [28,79,80,88,89]. However, 32
of these were diagnosed by IFA or EIA only [28,79,89]. None of these
one-tiered tested patients (EIA or IFA only) can be deﬁnitively consid-
ered to have Lyme Borreliosis without further conﬁrmatory testing. Of
the 28 positives described by Mayne [80], 15 were immunoblotted
without a supporting IFA result being published, severely hindering
the validity of these results. A further nine “positive” IgM results are
ruled out because of the lack of diagnostic value of the IgM results
when the clinical syndrome has been present for greater than 30 days.
The remaining four positives had only four or less of the 10 bands
required for positive IgG. A further 19 IFAs, 100 IgM immunoblots and
75 IgG immunoblots have also been reported as positive in Australian
patients presenting with a Lyme-like condition but also showing
concurrent positive antibody titres in several other infectious disease
serology tests [88]. It must be reiterated that in a non-endemic or low-
endemicity setting, cross reaction of non-speciﬁc antibodies due to
the presence of other diseases will often lead to the visualisation of
false-positive immunoblot bands. In summary, none of the published
Lyme-like illness cases from Australian patients diagnosed by serology
alone have met the minimum criteria for serological diagnosis of Lyme
Borreliosis as described in Section 3.1.
4.2. Culture from patients
Although biopsies of erythema migrans have been taken from nu-
merous Australian patients for histology or PCR [81,82,85,87], there
has only been one published report of Borrelia culture been successful
[84]. The case involved a patient that had sustained a tick bite while
walking in bushland of Pittwater Shire, Sydney. This was followed byerythemamigrans formation, headache and fever, and later generalised
arthalgias and myalgias, insomnia and recurrent skin lesions. Over
18 months after the initial tick bite a biopsy of one of the patient's
secondary erythema migrans lesions was cultured in BSK-II media.
Spirochaetes were present after three weeks incubation and were
identiﬁed by direct immunoﬂuorescent staining as B. garinii. Although
the disease appeared to follow the tick bite contracted in New South
Wales, this patient had also travelled to three Lyme-endemic countries
in Europe 17months before the onset of his symptoms [84]. Whilst this
published case demonstrates a culture conﬁrmed Lyme Borreliosis-
causing Borrelia isolate in an Australian patient, Australian acquisition
could not be conﬁrmed.4.3. Molecular detection of B. burgdorferi s. l. from patients
Borrelia burgdorferi s. l. DNAhas been detected and sequenced in ﬁve
Australian patients presentingwith Lyme-like disease. Three patient er-
ythemamigrans biopsieswere tested for B. burgdorferi s. l. using primers
coding for Borrelial rpoC [87]. The publication stated that sequencing of
the products revealed a 99% homology with B. burgdorferi s. s. One of
these patients had never left Australia. However, the primer sequences
were not published and the three sequences differed signiﬁcantly in
size, being 206 bp, 336 bp and 165 bp long [87], suggesting non-
speciﬁc cross-priming. Another erythema migrans rash biopsy was
tested using a duplex PCR targeting borrelial ospC and 16SrRNA. The
paper states that the ospC PCR yielded an amplicon 83 bp long [87].
However, analysis of the ospC primers utilized in the study using the
NCBI Primer Designing Tool (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/) shows an expected amplicon of 104–113 bp in length.
Thus, non-speciﬁc ampliﬁcation may have led to the positive PCR reac-
tion. The same author reported elsewhere an Australian erythema
migrans biopsy yielding a product with a Borrelia 16SrRNA PCR once
again having a 99% homology with B. burgdorferi s. s. [86]. The sequence
of the amplicon was not provided, and the primer sequences were also
withheld [86]. The laboratory concerned has, to date, yet to share their
primer sequences, nor any DNA or isolates with other researchers for
independent veriﬁcation. A further 126 positive Borrelia PCRs on blood
samples and 46 on urine samples have been reported, but no sequenc-
ing was performed to conﬁrm the amplicon identities, and the primers
were once again not disclosed [88]. Many of the abovementioned
patients also had overseas travel histories [88]. Given the controversy
surrounding the possibility of Lyme Borreliosis transmission in
Australia, unequivocal demonstration of the local acquisition of
B. burgdorferi s. l. within this country would be best supported by both
a cultured isolate (stored for analysis by other laboratories, including a
recognised reference laboratory skilled in the identiﬁcation of such iso-
lates) and positive direct molecular identiﬁcation from clinical material
(conﬁrmed by sequencing) from a patient with absolutely no history of
overseas travel.4.4. Seroprevalence in the population
It would be expected that if the putative Lyme-like disease
in Australia is caused by B. burgdorferi s. l., there would be a high
seropositive rate in the Australian population and an even higher
seroprevalence in reservoir hosts. However, the seroprevalence rate of
B. burgdorferi s. l. using IgG ELISA in residents of coastal New South
Wales was found to be 2.2% (9/400) and in dogs of this area the preva-
lence was 2.5% (6/239) [90]. Conversely, in Westchester County, New
York (endemic for Lyme), 49.2% of dogs were seropositive, ranging
from 6.5% to 85.2% depending on the municipality [91] and in New
Jersey by IFA, 34.7% of asymptomatic dogs were seropositive [92]. In
the Aland Islands of Finland (also Lyme endemic), 19.7% of residents
were positive for B. burgdorferi s. l. IgG with ELISA [93].
Table 1
Geographic distribution of Australian Lyme-like cases from peer-reviewed scientiﬁc literature.
Location Travel history Symptoms Laboratory ﬁndings Diagnosis by culture/PCRa Reference
Lower Hunter Valley, NSW ND Insect bite followed by EM with secondary lesions,
relapsing arthritis with swelling and pain in the knee
and left hip, behavioural change, headaches, memory
loss, urinary retention, tachycardia.
Biopsy showed perivascular lymphocytic inﬁltrate.
Synovial ﬂuid from left knee 50 × 10 [6]/L, 70%
lymphocytes.
CSF raised protein (1.24 g/L) normal cell count. EEG
and CAT scan unremarkable. Diagnosed with mild
meningoencephalitis.
ECG-documented supraventricular tachycardia
without evidence of atrioventricular block.
Negative arbovirus serology (RRV, Sindbis virus,
Australian encephalitis virus)
NP/NP [82]
Guerilla Bay near Moruya, NSW ND Insect bite followed by EM. Weeks after treatment, EM
recurred.
Biopsy showed superﬁcial and deep perivascular
inﬁltrate of lymphocytes.
NP/NP [81]
North Bendalong (between
Nowra and Ulladulla), NSW
ND One month EM, lassitude, polyarthralgia, headaches. Biopsy showed dense perivascular inﬁltrate of
lymphocytes in full thickness of the dermis, some with
eosinophils.
NP/NP [81]
Gorokan, NSW ND 3 weeks of increasing lethargy, malaise, intermittent
fevers, multiple EM, severe occipital headache, sore
throat.
Biopsy showed mixed acute and chronic inﬁltration in
superﬁcial dermis. No spirochaetes on silver staining.
ESR and C1q binding assay elevated. Negative culture.
Syphilis serology, antinuclear factor, antistreptolysin
O titre and immunoglobin all normal levels
Paired sera CDC ELISA showed optical density ratio of
0.02 (acute serum) and 0.05 (convalescent serum)
when compared with strongly positive reference
serum. This is below the 0.2 ratio expected in patients
with late or complicated Lyme disease (but this
patient only early Lyme disease).
Negative/NP [85]
Pittwater Shire, Sydney 17 months prior to tick bite, visited 3
countries in Europe known to be endemic
for Lyme. Did not recall any tick bites or
exposure to ticks. EM appeared at the
Australian tick bite site.
EM at tick bite site. Mild headache, malaise and low
grade fever, non-pruritic rash, insomnia, generalised
arthralgias, myalgias,
insomnia, difﬁculty with memory and "thinking
clearly”, secondary EM lesions. Duration N18 months
ELISA B. burgdorferi s. s. antibody negative.
Western blot 2+ antibodies (one level below
strongest staining intensity) to outer surface protein A
(OspA) of B. garinii only.
Biopsy of secondary lesion showed mild, mainly
perivascular lymphohistiocytic inﬂammatory cell
inﬁltrate in superﬁcial dermis, minimal exocytosis, a
little pigment incontinence, no organisms
demonstrated with PAS, Gram or Warthin–Starry
Positive/positive (NS) [84]
(continued on next page)
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Table 1 (continued)
Location Travel history Symptoms Laboratory ﬁndings Diagnosis by culture/PCRa Reference
stains.
Culture of biopsy grew spirochaetes
Direct immunoﬂuorescence antibody staining to
ﬂagellin protein of B. burgdorferi s. l. and PCR of the
ﬂagellin and 16S rRNA identiﬁed B. garinii more
closely related to European rather than Asiatic
B. garinii strains.
152.8E, 31.66S Yes EM, no systemic illness rpoC PCR positive NP/positive-sequencing showed
99% identity match to
B. burgdorferi strain N40
[87]
152.7E 31.73S Never left Australia EM, systemic illness rpoC PCR positive NP/positive-sequencing showed
99% identity match to
B. burgdorferi strain N40
[87]
151.3E, 33.74S Yes EM, fever, meningism, severe headache worse with
coughing and shaking of head, photophobia and
retro-orbital pain.
rpoC PCR positive
Follow-up testing post-treatment revealed:
B. burgdorferi IgA, G, M negative.
B. burgdorferi multiplex PCR negative (primer targets
not speciﬁed).
Babesia and Bartonella serology negative.
NP/positive-sequencing showed
98% identity match to
B. burgdorferi strain N40
[87]
152.8E, 31.32S Never left Australia EM, no systemic illness Multiplex primer set 16S rRNA and OspC used — but
only one product sequence is provided. Unclear if both
or only one set was positive.
NP/positive-sequencing result
inconclusive.
[87]
Rural Victoria ND Fever, regular presumed viral illness, chronic fatigue
syndrome. Severe arthritis in hands, auditory
hypercusis, poor concentration, irritability and
emotional lability, episodic sleep disturbances, two
episodes of severe generalized body pain without
cause, one episode of auditory hallucinations and
paranoid ideas. Duration: 8 years
Diagnosed with ﬁbromyalgia at 17 yrs ld
Lyme serology IgG titre 80 and IgM titre 10.
NP/NP [79]
Mid-north coast of NSW Travelled from Byron Bay NSW to
Eastlakes Victoria. No overseas travel.
Lyme-like presentation Lyme IgM western blot bands 23–25, 39 and 41 kDa.
B. henselae IgM serology positive (titre 1:40).
NP/NP [80]
QLD Travelled to northern NSW and Sydney,
NSW; Melbourne, Victoria; Hobart,
Tasmania. No overseas travel.
Lyme-like presentation Lyme IFA 1:40. Lyme IgM western blot bands 31 and
41 kDa. Positive Borrelia plasmid PCR. Babesia duncani
IgG serology positive 1:40, Babesia microti IgG
serology positive 1:40, Bartonella henselae IgM
serology positive 1:40.
NP/positive (NS) [80]
Armstrong beach, QLD Karratha, WA. No overseas travel. Lyme-like presentation Lyme IFA serology 1:80, Lyme IgM western blot bands
34 and 41 kDa, Bartonella IgG serology positive 1:40.
NP/negative [80]
NSW Victoria, Queensland, South Australia. No
overseas travel.
Lyme-like presentation Lyme IgM western blot bands 31 and 41 kDa. Babesia
duncani IgG positive 1:40.
NP/negative [80]
ND, no data; NP, not performed; NS, not sequenced; EM, erythema migrans; ESR, erythrocyte sedimentation rate; PCR, polymerase chain reaction; EEG, electroencephalogram; CAT, computerized axial tomography; ECG, electrocardiogram; CSF,
cerebrospinal ﬂuid; RRV, Ross river virus; NT, northern territory; WA, western Australia; QLD, Queensland; NSW, New South Wales; VIC, Victoria; and TAS, Tasmania.
a Serological conﬁrmation of Lyme Borreliosis in the context of non-endemicity is questionable; diagnosis by culture and molecular identiﬁcation methods are preferable for conﬁrmation in the Australian setting.
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5.1. Infectious diseases
It is assumed bymany that the causative agent of Lyme-like illness in
Australia must be tick-borne. As noted in a previous section, almost all
Australian Lyme-like illness predominantly present with a condition
analagous to chronic Lyme Borreliosis. Indeed, it is unusual that not
more acute Lyme Borreliosis cases are identiﬁed in humans and animals
within Australia if the organism causing this illness was indeed B.
burgdorferi s. l. Any putative agent of the Australian Lyme-like disease
would be capable of producing a syndrome similar to Lyme Borreliosis,
with a clinical presentation including ﬂu-like symptoms followed by
arthralgic, neurological, dermatological and/or cardiac complications.
Some Australian bacteria, parasites and viruses individually, or in co-
infection with other pathogens, might produce such a syndrome. A
summary of known Australian endemic infectious agents that might
be considered in the differential diagnosis of an Australian patient
with a Lyme-like presentation is presented below.
The clinical presentations of the Australian Rickettsioses are quite
similar to each other and atypical presentations may mimic an acute
Lyme Borreliosis. Symptoms include headache, chills, malaise, fever,
lymphadenopathy, maculopapular rash and an eschar found at the
tick bite site [94,95]. Sometimes arthralgias and myalgias may also be
present [94,96]. In some cases, the eschars may be absent [96,97] and
the rash may appear as varicelliform [94] or petechial [97]. In rare
cases, the rashwill not develop at all [97]. Rickettsial infections present-
ing without a maculopapular rash could be mistaken for a Lyme-like
illness.
In Australia, Babesia canis vogeli is found throughout northern and
central Australia and is spread by Rhipicephalus sanguineus ticks [98].
Babesia gibsoni has been described in dogs in Victoria [98]. Babesia
bovis and Babesia bigemina in cattle are spread by the Australian cattle
ticks R. australis [99,100]. Babesia equi (later known as Theileria equi
[101]) was brieﬂy introduced to Australia in 1976 [102,103] but this
did not spread and become established due to the absence of suitable
vectors [106]. B. bovis has been reported as a rare cause of infection in
humans [104]. The ﬁrst deﬁnitive case of human Babesiosis acquired
in Australia was reported in 2012 and was caused by Babesia microti
[105]. To date, B. microti has not been identiﬁed in any Australian
ticks. Babesia infection can be atypically associated with rheumatoid
muscular pains, and nervous complications including incoordination
of legs and hysteria, restlessness and nervousness [106]. It therefore
appears that Babesia is capable of mimicking a Lyme-like syndrome.
Like B. burgdorferi s. l., Babesia is also capable of establishing long-
term, persistent infection [107].
Coxiella burnetii may also be considered in patients with tick bite
history and reporting Lyme-like symptoms. The majority of cases of
C. burnetii infection are asymptomatic, but in symptomatic infections
the most prevalent acute symptoms include fever (95%), headaches
(53%) and myalgia (38%) [108]. Other manifestations may include
hepatitis, pneumonia, meningitis, meningoencephalitis, pericarditis
and myocarditis [108–110]. Chronic infection may manifest as
endocarditis, vascular infections, osteoarticular infections, chronic
hepatitis, pericarditis and very rarely as adenopathies, lung or splenic
pseudotumours, or chronic neuropathy [108,111–114]. Therefore Q
fever may sometimes present as an infection similar to Lyme carditis
or Lyme neuroBorreliosis.
Many tick species have been shown as capable of carrying Bartonella
spp. including: I. ricinus, Dermacentor occidentalis, Dermacentor
variabilis, Dermacentorreticulatus, H. longicornis, Harperocallis ﬂava,
Ixodes nipponensis, Ixodes paciﬁcus, Ixodes persulcatus, I. ricinus, Ixodes
scapularis, Ixodes turdus, Ixodes antechini, Ixodes australiensis, I. tasmani,
Ixodes trichosuri and Rhipicephalus sanguineus [115–119]. Presently,
only Bartonella henselae [120–124] and Bartonella quintana [125] have
been reported to cause disease in Australian residents. However, anumber of other Bartonella species of unknown clinical signiﬁcance
have been identiﬁed in Australian animals and their parasites [116,
117,119,125,126].
B. henselae infection (cat scratch disease) is typically associated with
isolated lymphadenopathy with fever without any other symptoms
[128]. However it is now recognised that Bartonellamay cause a wide
spectrum of atypical manifestations even in immunocompetent pa-
tients [127–130]. Atypicalmanifestationsmaymimic a Lyme-like illness
[131] including rheumatic manifestations [131–133], ﬁbromyalgia and
chronic fatigue syndrome [131,134], neurological disease [135–137]
and endocarditis [138,139]. B. henselae been associated with erythema
marginatum rashes [130] that may be mistaken for an erythema
migrans rash. Like B. burgdorferi s. l., B. henselae is capable of sustaining
chronic infection [134,140,141].
DNA sequences of a newly discovered organism, Candidatus
Neoehrlichia, were recovered from ﬁfteen New South Wales
I. holocyclus ticks tested by Gofton, et al. [75]. These sequences did not
conform to the emerging tick-borne pathogen Ca.s Neoehrlichia
mikurensis, but did cluster within two clusters belonging to the Ca.
Neoehrlichia group [75] and later designated “Ca. Neoehrlichia species
A and B” [76]. The two species were detected in 248 I. holocyclus ticks
from both eastern and Western Australia by 16s rRNA next generation
sequencing, though when a Ca. Neoehrlichia species A and B speciﬁc
nested PCR was applied to the same samples, only 36 were positive
[76]. Candidatus Neoehrlichia mikurensis has previously been detected
in rodents, humans and ticks from Europe and Asia [75]. A review of
eleven human cases in Europe showed that all but one patient were
actively immunosuppressed, and most were asplenic [142]. Symptoms
included fever, myalgia, arthralgia, neutrophilia and anaemia combined
with vascular events such as transient ischaemic attacks and deep vein
thrombosis [142]. Only ﬁve of the patients recalled being bitten by a tick
[142].While some of these described symptomsmay be confusedwith a
Lyme-like illness, further work must be performed to determine the
host range, infectivity and clinical presentation of the two novel Ca.
Neoehrlichia species detected in Australian I. holocyclus ticks before
these may be conﬁrmed as potential Lyme-like disease candidates.
Furthermore, other novel candidate infectious agents such as the three
new species each of Anaplasma and Ehrlichia that have been identiﬁed
by next generation sequencing of Australian ticks, though at much
lower prevalence than the novel species of Ca. Neoehrlichia species,
also require investigation [76].
5.2. Non-infectious diseases
It is important that potential non-infectious causes are considered in
the investigation of Australian patients presenting with a Lyme-like ill-
ness. Fibromyalgia, chronic fatigue syndrome, delusional parasitosis and
multiple sclerosis are examples of conditions that may bemisdiagnosed
as a Lyme-like disease, especially in Australia where the infectious
aetiology for this condition has not been elucidated. This list is by no
means exhaustive.
It should be noted that antigens in I. holocyclus saliva alone may
cause an erythematous rash to develop in bitten patients [143].
Of forty-two volunteers inoculated by pin-prick with an extract of
I. holocyclus salivary glands, 36% developed a local erythematous lesion
at that site within minutes or hours [143]. In most cases, the rash was
N50 mm in diameter and persisted for up to 7 days or more [143].
Such a hypersensitivity rash might easily be mistaken for an erythema
migrans lesion in patients recently bitten by I. holocyclus ticks [143].
These ﬁndings do raise a question as whether the Australian presenta-
tions of a Lyme-like illness may in some cases be an allergic response
by some individual patients to antigens found within local tick saliva.
Symptoms of ﬁbromyalgia include widespread musculoskeletal
pain, hyperalgesia, fatigue, insomnia, memory loss and poor concentra-
tion, depression, headache and irritable bowel syndrome [144–146].
Since diffuse arthralgia, cognitive difﬁculties and fatigue are common
52 M.J. Chalada et al. / One Health 2 (2016) 42–54in chronic LymeBorreliosis, it is possible forﬁbromyalgia to bemistaken
for Lyme borrelioisis and vice versa [147,148].
Chronic fatigue syndrome is very similar to ﬁbromyalgia in that it is a
syndrome of unknown aetiology characterised by persistent fatigue,
musculoskeletal pain, insomnia and cognitive impairment and
headaches [149–151]. Both syndromes are more common in women
than men, and the two syndromes commonly co-occur. It has even
been suggested that the two syndromes aremerely symptom ampliﬁca-
tion of the same somatic syndrome [149]. Fibromyalgia is diagnosed
based on widespread musculoskeletal pain, sensitivity in a number of
“tender spots”, and the presence of other associated symptoms such
as headaches, sleep disturbances and memory loss [152]. Chronic fa-
tigue syndrome diagnosis is based on onset of unexplained persistent
or relapsing chronic fatigue that is not substantially alleviated by rest,
accompanied by symptoms such as short termmemory or poor concen-
tration, sore throat or lymph nodes, muscle or joint pain and headaches
[150]. Chronic fatigue and ﬁbromyalgia may present as sequelae of
infections with C. burnetii, Chlamydophila pneumoniae, Epstein-Barr
virus and Parvovirus B19 [150].
Delusional parasitosis is a psychiatric disorder where a patient has
the false but ﬁxed belief that they are being infested by parasites [153,
154]. It may present as a primary somatic disorder or secondary to
other conditions such as drug use, schizophrenia or dementia. Primary
delusional parasitosis occurs most commonly in middle-aged women,
and except for their delusion the patient may otherwise be rational
andmentally healthy [153]. Patientsmay describe sensations of parasit-
ic activity on or under their skin such as crawling, biting or burrowing
(collectively known as formication), and may bring in objects such as
hair, lint or skin as evidence of their infestation despite unremarkable
ﬁndings on examination [153,154].
There has been one published Australian case of delusional parasito-
sis in which the patient was convinced she had Lyme Borreliosis [155].
The patient brought evidence of “ticks” to her doctor and presented
with rashes as a result of scratching and disinfecting. The patient had
shaved off all her hair and fumigated her house in an attempt to be rid
of the arthropods. However after several months of cognitive behav-
ioural therapy and 150 mg of venlafaxine, her paranoia and symptoms
were successfully alleviated [155].
6. Conclusion
Suggestions that a Lyme-like disease may exist in Australia [17]
remain controversial and no study to date has deﬁnitively identiﬁed
the presence of a Borrelia species infecting humans that have a locally
acquired Lyme-like syndrome. It is unclear whether the causative
agent of this purported condition is a B. burgdorferi s. l. related organism,
another pathogen altogether or of non-infectious aetiology. Over 500
Lyme-like cases from Australian patients have been published in the
scientiﬁc literature [79–82,84–89] and two bovine cases [28] but upon
investigation, these diagnoses were highly questionable due to signiﬁ-
cant ﬂaws in the diagnostic process or presentation of results. Only in
one instance has a Lyme Borreliosis-causing Borrelia species been
cultured from an Australian patient or animal [84]. This patient had a
history of travel to a Lyme endemic area of the northern hemisphere
[84] so overseas acquisition cannot be ruled out. Serology has a low
positive predictive value in non-endemic areas and cannot be relied
upon for diagnosis. The reported culture of possible Borrelia spiro-
chaetes from 109 Australian ticks [66] was not reproduced in over
10,000 ticks [73]. B. burgdorferi s. l. has never been cultured from an
Australian patient that could not have acquired the infection overseas
and therefore there is currently no proof that B. burgdorferi s. l. or any
other kinds of Borrelia species are infecting humans in Australia. If
there is a Lyme-like disease that exists in Australia it may well be of a
different aetiology. It is recommended by the authors that in the non-
endemic context such as Australia, in addition to following the RCPA
protocol for the diagnostic laboratory testing of Borreliosis [59], aminimum of live Borrelia culture combined with a positive, sequenced
B. burgdorferi s. l. speciﬁc PCR and independent veriﬁcation of the iden-
tity of that organism by an experienced reference laboratory is required
to conﬁrm any future diagnosis of Australian acquired Lyme Borreliosis.
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